Article
An additional patient with SMAD4-Juvenile Polyposis-Hereditary hemorrhagic telangiectasia and connective tissue abnormalities: SMAD4 loss-of-function and gain-of-function pathogenic variants result in contrasting phenotypes.
American journal of medical genetics. Part A - 1 Oct 2022
Gheewalla Gregory M, Luther Jay, Das Saumya, Kreher Jeffrey B, Scimone Eleanor R, Wong Ashley W, Lindsay Mark E, Lin Angela E
Abstract excerpt
Loss-of-function pathogenic variants in somatic and germline cells in SMAD4 may cause cancer and juvenile polyposis-Hereditary Hemorrhagic Telangiectasia (SMAD4-JP-HHT), respectively. In a similar manner, gain-of-function somatic and germline pathogenic variants in SMAD4 can cause various forms of cancer as well as Myhre syndrome. The different SMAD4 molecular mechanisms result in contrasting clinical phenotypes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
